Clinical Trials Browser

Completed × Neoplasms × gilteritinib × Clear all

NCT03625505 2021-09-14

A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1 Completed

Other hematologic neoplasm

Neoplasms, Recurrence, Leukemia, Myeloid, Acute